Literature DB >> 20043006

Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding.

Vibe G Frokjaer1, Maj Vinberg, David Erritzoe, William Baaré, Klaus Kähler Holst, Erik Lykke Mortensen, Haroon Arfan, Jacob Madsen, Terry L Jernigan, Lars Vedel Kessing, Gitte Moos Knudsen.   

Abstract

Life stress is a robust risk factor for later development of mood disorders, particularly for individuals at familial risk. Likewise, scoring high on the personality trait neuroticism is associated with an increased risk for mood disorders. Neuroticism partly reflects stress vulnerability and is positively correlated to frontolimbic serotonin 2A (5-HT(2A)) receptor binding. Here, we investigate whether neuroticism interacts with familial risk in relation to frontolimbic 5-HT(2A) receptor binding. Twenty-one healthy twins with a co-twin history of mood disorder and 16 healthy twins without a co-twin history of mood disorder were included. They answered self-report personality questionnaires and underwent [(18)F]altanserin positron emission tomography. We found a significant interaction between neuroticism and familial risk in predicting the frontolimbic 5-HT(2A) receptor binding (p=0.026) in an analysis adjusting for age and body mass index. Within the high-risk group only, neuroticism and frontolimbic 5-HT(2A) receptor binding was positively associated (p=0.0037). In conclusion, our data indicate that familial risk and neuroticism interact in their relation to frontolimbic 5-HT(2A) receptor binding. These findings point at a plausible neurobiological link between genetic and personality risk factors and vulnerability to developing mood disorders. It contributes to our understanding of why some people at high risk develop mood disorders while others do not. We speculate that an increased stress reactivity in individuals at high familial risk for mood disorders might enhance the effect of neuroticism in shaping the impact of potential environmental stress and thereby influence serotonergic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20043006      PMCID: PMC3055406          DOI: 10.1038/npp.2009.218

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  52 in total

1.  A Swedish national twin study of lifetime major depression.

Authors:  Kenneth S Kendler; Margaret Gatz; Charles O Gardner; Nancy L Pedersen
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

2.  Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions.

Authors:  Deborah S Hasin; Renee D Goodwin; Frederick S Stinson; Bridget F Grant
Journal:  Arch Gen Psychiatry       Date:  2005-10

Review 3.  The genetics of depression: a review.

Authors:  Douglas F Levinson
Journal:  Biol Psychiatry       Date:  2005-11-21       Impact factor: 13.382

4.  Personality and major depression: a Swedish longitudinal, population-based twin study.

Authors:  Kenneth S Kendler; Margaret Gatz; Charles O Gardner; Nancy L Pedersen
Journal:  Arch Gen Psychiatry       Date:  2006-10

Review 5.  Fetal origins of stress-related adult disease.

Authors:  Eero Kajantie
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

6.  Enhanced early morning salivary cortisol in neuroticism.

Authors:  Maria J Portella; Catherine J Harmer; Jonathan Flint; Philip Cowen; Guy M Goodwin
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

7.  Stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression.

Authors:  Nele Jacobs; Gunter Kenis; Frenk Peeters; Catherine Derom; Robert Vlietinck; Jim van Os
Journal:  Arch Gen Psychiatry       Date:  2006-09

8.  The DSM-IV and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: evidence that they lie on a dimensional spectrum.

Authors:  Hagop S Akiskal; Franco Benazzi
Journal:  J Affect Disord       Date:  2006-02-20       Impact factor: 4.839

Review 9.  Strategy for investigating interactions between measured genes and measured environments.

Authors:  Terrie E Moffitt; Avshalom Caspi; Michael Rutter
Journal:  Arch Gen Psychiatry       Date:  2005-05

10.  Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.

Authors:  Zubin Bhagwagar; Rainer Hinz; Matthew Taylor; Sabrina Fancy; Philip Cowen; Paul Grasby
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

View more
  17 in total

Review 1.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

2.  Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder.

Authors:  Paul H Soloff; Laurel Chiappetta; Neale Scott Mason; Carl Becker; Julie C Price
Journal:  Psychiatry Res       Date:  2014-03-29       Impact factor: 3.222

3.  LSD-induced entropic brain activity predicts subsequent personality change.

Authors:  A V Lebedev; M Kaelen; M Lövdén; J Nilsson; A Feilding; D J Nutt; R L Carhart-Harris
Journal:  Hum Brain Mapp       Date:  2016-05-06       Impact factor: 5.038

Review 4.  The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse.

Authors:  Jacob P R Jacobsen; Ivan O Medvedev; Marc G Caron
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

5.  Cerebral 5-HT2A receptor and serotonin transporter binding in humans are not affected by the val66met BDNF polymorphism status or blood BDNF levels.

Authors:  Anders Bue Klein; Viktorija Trajkovska; David Erritzoe; Steven Haugbol; Jacob Madsen; William Baaré; Susana Aznar; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

6.  Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.

Authors:  Dea Siggaard Stenbaek; Sara Kristiansen; Daniel Burmester; Martin Korsbak Madsen; Vibe Gedsoe Frokjaer; Gitte Moos Knudsen; Patrick MacDonald Fisher
Journal:  Hum Brain Mapp       Date:  2019-01-11       Impact factor: 5.038

7.  The association between negative affect and prescription opioid misuse in patients with chronic pain: the mediating role of opioid craving.

Authors:  Marc O Martel; Andrew J Dolman; Robert R Edwards; Robert N Jamison; Ajay D Wasan
Journal:  J Pain       Date:  2013-10-12       Impact factor: 5.820

Review 8.  Regulating prefrontal cortex activation: an emerging role for the 5-HT₂A serotonin receptor in the modulation of emotion-based actions?

Authors:  Susana Aznar; Anders B Klein
Journal:  Mol Neurobiol       Date:  2013-05-22       Impact factor: 5.590

Review 9.  5-HT radioligands for human brain imaging with PET and SPECT.

Authors:  Louise M Paterson; Birgitte R Kornum; David J Nutt; Victor W Pike; Gitte M Knudsen
Journal:  Med Res Rev       Date:  2011-06-14       Impact factor: 12.944

10.  Serotonin receptor expression in human prefrontal cortex: balancing excitation and inhibition across postnatal development.

Authors:  Evelyn K Lambe; Stu G Fillman; Maree J Webster; Cynthia Shannon Weickert
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.